Clinical Trials on Breast Tumour
Total 30364 results
-
University of Colorado, DenverCompletedMetastatic Breast Cancer | Solid TumorsUnited States
-
NBE-Therapeutics AGCmed Clinical ServicesTerminatedTriple Negative Breast Cancer | Advanced Solid Tumor | Advanced CancerUnited States
-
iOMEDICO AGNovartis PharmaceuticalsCompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast CancerGermany
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
Poitiers University HospitalRecruitingBreast Cancer | Gynecologic Cancer | Circulating Tumor DNA | Digestive Cancer | ExosomesFrance
-
Merck Sharp & Dohme LLCCompletedAdvanced Breast Cancer | Other Solid Tumors
-
Northwestern UniversityNational Cancer Institute (NCI); AmgenTerminatedStage IV Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Breast Carcinoma Metastatic in the Bone | Circulating Tumor Cell CountUnited States
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
Bristol-Myers SquibbCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.WithdrawnBreast Cancer | Solid TumorChina
-
German Breast GroupNovartisCompletedBreast Cancer | Hormone Receptor Positive TumorGermany
-
Merrimack PharmaceuticalsCompletedMetastatic Breast Cancer | Her2 Amplified Solid TumorsUnited States
-
Excel Diagnostics and Nuclear Oncology CenterWithdrawnNeuroendocrine Tumors | Pheochromocytoma | Paraganglioma | Unknown Primary Tumors | Pulmonary Neuroendocrine Neoplasm | Thymus Carcinoid | Neuroendocrine Skin Carcinoma | Neuroendocrine Breast Tumor | Neuroendocrine Carcinoma Metastatic | Neuroendocrine Neoplasm of OvaryUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Eisai Co., Ltd.CompletedBreast Cancer | Breast Tumors | Triple Negative Breast Cancer | Cancer of Breast | HER2-Negative Breast CancerChina
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
PfizerRecruitingBreast Cancer | Solid TumorsChina, United States, Mexico, Bulgaria, Spain, Brazil, Czechia, Argentina, South Africa
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
TransThera Sciences (Nanjing), Inc.Active, not recruitingAdvanced Solid Tumors | Triple Negative Breast CancerUnited States, China
-
National University Hospital, SingaporeNot yet recruitingOther Solid Tumors | HER2+ Advanced Breast Cancer
-
Nippon Kayaku Co., Ltd.CompletedAdvanced Solid Tumors | Metastatic Triple Negative Breast CancerUnited States
-
NantCell, Inc.CompletedBreast Cancer | Metastatic Cancer | Breast TumorsUnited States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland
-
Alice ChungNot yet recruitingBreast Cancer | Mastectomy; Lymphedema | Female Breast Cancer | Axilla; Breast | Tumor, Breast | Axillary Nodal Disease
-
Institut BergoniéRoche Pharma AG; National Cancer Institute, France; Eikon TherapeuticsRecruitingMelanoma | Pancreatic Cancer | Non Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | Solid Tumor, Adult | Virus-associated TumorsFrance
-
Prof. W. JanniActive, not recruitingHER2-negative and Hormone-receptor Positive Metastatic Breast Cancer | HER2-negative Circulating Tumor Cells | Postmenopausal Female PatientsGermany
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Hunan Cancer HospitalCompletedMetastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality
-
AmgenTerminatedBreast Cancer | Breast Neoplasms | Breast Tumors | Locally Recurrent and Metastatic Breast Cancer
-
University of Roma La SapienzaCompletedStage I Breast Cancer | Cancer, Treatment-Related | Systemic Inflammatory Response | Tumor of BreastItaly
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant NeoplasmItaly
-
Instituto Nacional de Ciencias Medicas y Nutricion...UnknownTriple-Negative Invasive Breast Carcinoma | Residual TumorMexico
-
TYK Medicines, IncRecruiting
-
Gangnam Severance HospitalRecruitingMastectomyKorea, Republic of
-
Hunan Cancer HospitalCompletedMetastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality
-
Mayo ClinicCompletedBreast Cancer | Dense BreastsUnited States
-
Mayo ClinicCompleted
-
HiberCell, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Melanoma | Triple-Negative Breast CancerUnited States
-
Washington University School of MedicineCompletedMelanoma | Breast Cancer | Malignant Melanoma | Cancer of Breast | Cancer of the BreastUnited States
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Malignant Solid TumorsUnited States, Taiwan, United Kingdom, Hong Kong, Belgium, France, Spain, China, Netherlands, Poland, Sweden
-
Novartis PharmaceuticalsCompletedLymphoma | Breast Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Melanoma (Skin) | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic SyndromeUnited States
-
University of UtahCelgene CorporationCompletedAdvanced or Metastatic Solid Tumors | Advanced or Metastatic Breast CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)WithdrawnKidney Cancer | Testicular Germ Cell Tumor | Breast Cancer | Lung Cancer | Melanoma (Skin)
-
Shandong Cancer Hospital and InstituteNot yet recruitingHER2-positive Breast Cancer
-
Centre Jean PerrinTerminated
-
IpsenCompletedMidgut Neuroendocrine Tumours | Pancreatic TumoursSpain, United Kingdom, Denmark, Belgium, Germany, France, Netherlands, Ireland, Italy, Poland
-
NanobiotixRecruitingMetastatic Renal Cell Carcinoma | Squamous Cell Carcinoma of Head and Neck | Radiotherapy | Immunotherapy | Microsatellite Instability-High Solid Malignant Tumour | Metastasis From Malignant Tumor of Liver | Metastasis From Malignant Tumor of Cervix | Metastasis From Malignant Melanoma of Skin (Disorder) and other conditionsUnited States
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany